Innate and Adaptive Immunity in Calcific Aortic Valve Disease

Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Marie‐Chloé Boulanger(Institut Universitaire de Cardiologie et de Pneumologie de Québec)
Journal of Immunology Research
January 1, 2015
10.1155/2015/851945
Cited by 115

Related Papers

A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
|npj Genomic Medicine|2019|174
OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-κB pathway
|Cardiovascular Research|2017|94
Increased Biglycan in Aortic Valve Stenosis Leads to the Overexpression of Phospholipid Transfer Protein via Toll-Like Receptor 2
|American Journal Of Pathology|2010|71
Association of <i>FADS1/2</i> Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis
|JAMA Cardiology|2020|64
High Expression of the Pi-Transporter SLC20A1/Pit1 in Calcific Aortic Valve Disease Promotes Mineralization through Regulation of Akt-1
|PLoS ONE|2013|59